Shattuck Labs, Inc. Operating Leases, Future Minimum Payments, Due in Four Years
Shattuck Labs, Inc. (STTK) had Operating Leases, Future Minimum Payments, Due in Four Years of $1.15 million as of 2021-12-31, per its 10-K filed 2023-02-23.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFourYears · last filed 2023-02-23
- 2021-12-31: Operating Leases, Future Minimum Payments, Due in Four Years $1.15M.
- 2021-09-30: Operating Leases, Future Minimum Payments, Due in Four Years $1.12M.
- 2021-06-30: Operating Leases, Future Minimum Payments, Due in Four Years $1.12M.
- 2021-03-31: Operating Leases, Future Minimum Payments, Due in Four Years $1.12M.
| Period end | Operating Leases, Future Minimum Payments, Due in Four Years |
|---|---|
| 2021-12-31 | $1.15M 10-K · filed 2023-02-23 |
| 2021-09-30 | $1.12M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $1.12M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $1.12M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $775.00K 10-K · filed 2021-03-16 |
| 2020-09-30 | $753.00K 10-Q · filed 2020-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |